Catalog #SIM0046

InVivoSIM anti-human CTLA-4 (Tremelimumab Biosimilar)

Clone Tremelimumab
Reactivities Human
Applications CTLA-4 neutralization
Flow Cytometry
ELISA
Western Blot
Isotype Human IgG2, κ

$243.00 - $8,425.00

$243.00 - $8.00

Choose an Option...
  • 100 mg - $8,425.00
  • 50 mg - $4,734.00
  • 25 mg - $3,293.50
  • 5 mg - $943.00
  • 1 mg - $243.00
  • Custom Amount (Quotes Only)
In stock
Only %1 left
US Customers - Order within 2 hours, 52 minutes to receive by October 23.

Product Description

This biosimilar antibody uses the same variable regions from the therapeutic antibody Tremelimumab making it ideal for research use. This Tremelimumab biosimilar is a fully human monoclonal antibody which reacts with human CTLA-4 (cytotoxic T lymphocyte antigen-4) also known as CD152. CTLA-4 is a 33 kDa cell surface receptor encoded by the Ctla4 gene that belongs to the CD28 family of the Ig superfamily. CTLA-4 is expressed on activated T and B lymphocytes. CTLA-4 is structurally similar to the T-cell co-stimulatory protein, CD28, and both molecules bind to the B7 family members B7-1 (CD80) and B7-2 (CD86). Upon ligand binding, CTLA-4 negatively regulates cell-mediated immune responses. CTLA-4 plays roles in induction and/or maintenance of immunological tolerance, thymocyte development, and regulation of protective immunity. CTLA-4 is among a group of inhibitory receptors being used as cancer treatment targets through immune checkpoint blockade. Tremelimumab binds to CTLA-4, blocking the inhibitory signal, which allows the cytotoxic T cells to kill cancer cells. Tremelimumab and Ipilimumab are both fully human monoclonal antibodies directed against CTLA-4, but Ipilimumab is an IgG1 isotype and Tremelimumab is a non-complement-fixing IgG2 isotype.

Specifications

Isotype Human IgG2, κ
Recommended Dilution Buffer InVivoPure pH 7.0 Dilution Buffer
Mutations S378A
Immunogen Human CTLA-4
Reported Applications CTLA-4 neutralization
Flow Cytometry
ELISA
Western Blot
Formulation PBS, pH 7.0
Contains no stabilizers or preservatives
Endotoxin ≤0.5EU/mg (≤0.0005EU/μg)
Determined by LAL assay
Aggregation <5%
Determined by SEC
Purity ≥95%
Determined by SDS-PAGE
Sterility 0.2 µm filtration
Production Purified from cell culture supernatant in an animal-free facility
Purification Protein A
RRID AB_3696385
Molecular Weight 150 kDa
Murine Pathogen Tests Ectromelia/Mousepox Virus: Negative
Hantavirus: Negative
K Virus: Negative
Lactate Dehydrogenase-Elevating Virus: Negative
Lymphocytic Choriomeningitis virus: Negative
Mouse Adenovirus: Negative
Mouse Cytomegalovirus: Negative
Mouse Hepatitis Virus: Negative
Mouse Minute Virus: Negative
Mouse Norovirus: Negative
Mouse Parvovirus: Negative
Mouse Rotavirus: Negative
Mycoplasma Pulmonis: Negative
Pneumonia Virus of Mice: Negative
Polyoma Virus: Negative
Reovirus Screen: Negative
Sendai Virus: Negative
Theiler’s Murine Encephalomyelitis: Negative
Storage This product should be stored at the stock concentration at 4°C. Do not freeze.
Need a Custom Formulation? See All Antibody Customization Options

Product FAQs

Related Products

  1. Catalog #CP146
    RecombiMAb anti-mouse CTLA-4 (CD152) Read more
  2. Catalog #SIM0004
    InVivoSIM anti-human CTLA-4 (Ipilimumab Biosimilar) Read more
  3. Catalog #BP0032
    InVivoPlus anti-mouse CTLA-4 (CD152) Read more
  4. Catalog #BP0131
    InVivoPlus anti-mouse CTLA-4 (CD152) Read more
  5. Catalog #BP0164
    InVivoPlus anti-mouse CTLA-4 (CD152) Read more
  6. Catalog #BE0131
    InVivoMAb anti-mouse CTLA-4 (CD152) Read more
  7. Catalog #BE0164
    InVivoMAb anti-mouse CTLA-4 (CD152) Read more
  8. Catalog #BE0032
    InVivoMAb anti-mouse CTLA-4 (CD152) Read more
  9. Catalog #BE0190
    InVivoMAb anti-human CTLA-4 (CD152) Read more
  10. Catalog #CP006
    RecombiMAb anti-mouse CTLA-4 (CD152) Read more
  11. Catalog #CP008
    RecombiMAb anti-mouse CTLA-4 (CD152) (LALA-PG) Read more
  12. Catalog #CP007
    RecombiMAb anti-mouse CTLA-4 (CD152) Read more
  13. Catalog #BE0424
    InVivoMAb anti-rat CTLA-4 (CD152) Read more